longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Wolwo Pharma

300357

19.251.21% ( +0.23 )
Delay Closed: Sep 17, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 24.15, below the reasonable range, cheaper than 99.36% of the time in the past 3 years, and the industry ranks 59/221, the industry Median 23.07.

24.15xP/E
¥19.25Stock price
¥0.80Earnings per share
24.15xP/E
Stock price¥19.25Earnings per share¥0.80

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
37.36x
Typical range
31.99x–44.22x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.07x
019385776

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.07x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600276SHHengrui Pharma
37.14x17.99%¥286.93B
600436SHZZPZH
39.29x0.03%¥71.09B
002422SZKELUN PHARMA
34.81x15.33%¥63.66B
600085SHTRT
32.83x7.45%¥31.85B
000739SZAPELOA
31.47x23.79%¥26.75B
600329SHDRTG
30.91x51.62%¥26.21B
600521SHHuahaipharm
38.99x305.56%¥24.48B
002262SZNHWA
20.06x14.76%¥22.01B
600664SHHPGC
36.48x71.43%¥18.69B
603456SHJiuzhou Pharma
23.07x12.93%¥13.65B
603707SHNKF
25.00x11.11%¥12.07B
002019SZYifan Pharmaceutical
37.21x12.12%¥11.29B
600420SHSHYNDEC
20.35x--¥11.09B
600572SHCONBA
21.54x--¥10.74B
300357SZWolwo Pharma
24.15x18.88%¥10.08B
002626SZKingdomway
37.80x56.36%¥9.93B
688076SHSinopep
38.30x91.51%¥9.09B
300401SZGARDEN BIOPHARMA
31.89x56.86%¥8.78B
002332SZXJZY
21.89x5.56%¥8.45B
688513SHEASTON BIOPHARMACEUTICALS
30.28x0.00%¥8.40B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.